BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18448848)

  • 1. Terminal-decline effects for select cognitive tasks after controlling for preclinical dementia.
    Laukka EJ; MacDonald SW; Bäckman L
    Am J Geriatr Psychiatry; 2008 May; 16(5):355-65. PubMed ID: 18448848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting cognitive trajectories of impending death and preclinical dementia in the very old.
    Laukka EJ; MacDonald SW; Bäckman L
    Neurology; 2006 Mar; 66(6):833-8. PubMed ID: 16567699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive performance in very old diabetic persons: the impact of semantic structure, preclinical dementia, and impending death.
    Wahlin A; Nilsson E; Fastbom J
    Neuropsychology; 2002 Apr; 16(2):208-16. PubMed ID: 11949713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical cognitive trajectories differ for Alzheimer's disease and vascular dementia.
    Laukka EJ; Macdonald SW; Fratiglioni L; Bäckman L
    J Int Neuropsychol Soc; 2012 Mar; 18(2):191-9. PubMed ID: 22264384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Education delays accelerated decline on a memory test in persons who develop dementia.
    Hall CB; Derby C; LeValley A; Katz MJ; Verghese J; Lipton RB
    Neurology; 2007 Oct; 69(17):1657-64. PubMed ID: 17954781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dementia following bipolar disorder].
    Lebert F; Lys H; Haëm E; Pasquier F
    Encephale; 2008 Dec; 34(6):606-10. PubMed ID: 19081458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline in cognitive and functional skills increases mortality risk in nondemented elderly.
    Schupf N; Tang MX; Albert SM; Costa R; Andrews H; Lee JH; Mayeux R
    Neurology; 2005 Oct; 65(8):1218-26. PubMed ID: 16247048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of cognitive impairment and dementia in the community: a 9-year-long prospective study.
    Caracciolo B; Palmer K; Monastero R; Winblad B; Bäckman L; Fratiglioni L
    Neurology; 2008 May; 70(19 Pt 2):1778-85. PubMed ID: 18184916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar patterns of cognitive deficits in the preclinical phases of vascular dementia and Alzheimer's disease.
    Laukka EJ; Jones S; Small BJ; Fratiglioni L; Bäckman L
    J Int Neuropsychol Soc; 2004 May; 10(3):382-91. PubMed ID: 15147596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive deficits in preclinical Alzheimer's disease and vascular dementia: patterns of findings from the Kungsholmen Project.
    Bäckman L; Small BJ
    Physiol Behav; 2007 Sep; 92(1-2):80-6. PubMed ID: 17573076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trajectory of mild cognitive impairment onset.
    Howieson DB; Carlson NE; Moore MM; Wasserman D; Abendroth CD; Payne-Murphy J; Kaye JA
    J Int Neuropsychol Soc; 2008 Mar; 14(2):192-8. PubMed ID: 18282317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year follow-up of cognitive impairment with no dementia.
    Tuokko H; Frerichs R; Graham J; Rockwood K; Kristjansson B; Fisk J; Bergman H; Kozma A; McDowell I
    Arch Neurol; 2003 Apr; 60(4):577-82. PubMed ID: 12707072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing the limits and characteristics of normal age-related cognitive decline.
    Ritchie K; Touchon J; Ledésert B; Leibovici D; Gorce AM
    Rev Epidemiol Sante Publique; 1997 Oct; 45(5):373-81. PubMed ID: 9407625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroprotective effects of caffeine: a prospective population study (the Three City Study).
    Ritchie K; Carrière I; de Mendonca A; Portet F; Dartigues JF; Rouaud O; Barberger-Gateau P; Ancelin ML
    Neurology; 2007 Aug; 69(6):536-45. PubMed ID: 17679672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease.
    Palmer K; Bäckman L; Winblad B; Fratiglioni L
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):603-11. PubMed ID: 18591580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset and rate of cognitive change before dementia diagnosis: findings from two Swedish population-based longitudinal studies.
    Thorvaldsson V; Macdonald SW; Fratiglioni L; Winblad B; Kivipelto M; Laukka EJ; Skoog I; Sacuiu S; Guo X; Ostling S; Börjesson-Hanson A; Gustafson D; Johansson B; Bäckman L
    J Int Neuropsychol Soc; 2011 Jan; 17(1):154-62. PubMed ID: 21083966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal cognitive decline: accelerated loss of cognition in the last years of life.
    Wilson RS; Beck TL; Bienias JL; Bennett DA
    Psychosom Med; 2007; 69(2):131-7. PubMed ID: 17327212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective memory deterioration and future dementia in people aged 65 and older.
    Wang L; van Belle G; Crane PK; Kukull WA; Bowen JD; McCormick WC; Larson EB
    J Am Geriatr Soc; 2004 Dec; 52(12):2045-51. PubMed ID: 15571540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset of terminal decline in cognitive abilities in individuals without dementia.
    Thorvaldsson V; Hofer SM; Berg S; Skoog I; Sacuiu S; Johansson B
    Neurology; 2008 Sep; 71(12):882-7. PubMed ID: 18753475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.